The European pain management device market is growing moderately, and will be buoyed over the forecast period by the ongoing launch and growing adoption non-conservative premium-priced products. Nevertheless, the COVID-19 pandemic will limit growth in the initial years of the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for pain management devices in Europe across a 10-year period.

The COVID-19 pandemic will negatively impact the European pain management device market.

Which procedures and device segments will be most impacted?

At what pace are pain management device markets expected to recover?

The European RF ablation device market for pain management will grow due to increasing awareness and product advancements

How are competitors leveraging the patient base and tailoring their product portfolios to remain competitive?

What have been the advancements in the RF ablation devices to manage pain?

Despite high interest in rechargeable SCS implants among European physicians, a challenging reimbursement environment and constrained health care facility budgets will limit adoption of these devices.

How do SCS implant procedure volumes compare to other back pain treatments?

Which countries have most rapidly adopted SCS therapy as a back pain treatment?

Table of contents

  • Pain Management Devices - Market Insights - Europe

Author(s): Dhara Patel, MS Pharm

Dhara Patel is a research associate on the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at DRG (Part of Clarivate), specializing in capital equipment such as  infusion systems and healthcare IT markets. Dhara holds a Bachelor's degree in Pharmaceutical Sciences from the University of Mumbai and a Master's degree in Medicinal Chemistry from the National Institute of Pharmaceutical Education and Research, Mohali.